Navigating Diabetes Medications Safely

This chapter explores the prescription intricacies of SGLT2 inhibitors and GLP-1 agonists, focusing on the importance of renal function and eGFR levels in patient management. It discusses shared decision-making strategies, the upcoming oral semaglutide, and the cardiovascular benefits tied to these diabetes medications. Additionally, the chapter emphasizes careful monitoring when transitioning patients to insulin therapy while considering the continuation of certain other medications.